category,datetime,headline,id,image,related,source,summary,url
company,1769026159,Assessing Zoetis (ZTS) Valuation After Recent Share Price Weakness,138199062,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ZTS,Yahoo,"Context for Zoetis after recent share performance Zoetis (ZTS) has seen mixed share performance recently, with a small move higher over the past month but negative returns over the past 3 months and year. This has prompted closer attention from some investors. See our latest analysis for Zoetis. At a share price of US$123.24, Zoetis has seen a 90 day share price return decline of about 16% and a 1 year total shareholder return decline of about 25%, suggesting momentum has been fading as...",https://finnhub.io/api/news?id=08266af8782f650e2ff1ccbedb61c81c6fcf15df397d0eed4ff2e99d3671a5f2
company,1769014080,Zoetis Inc. stock underperforms Wednesday when compared to competitors despite daily gains,138213965,,ZTS,MarketWatch,Zoetis Inc. stock underperforms Wednesday when compared to competitors despite daily gains,https://finnhub.io/api/news?id=70513628aff0f1a69085318c8336f64329f3b0b57cb55721b11ae958728393fa
company,1768966529,Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment,138196182,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ZTS,Yahoo,"The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Letâ€™s take a look at how branded pharmaceuticals stocks fared in Q3, starting with Zoetis (NYSE:ZTS).",https://finnhub.io/api/news?id=7cb03432327c799e75160764b72824223fc64675021e5bb00aa2d0c5cd99b25f
